03.06.2013 17:51 Uhr, Quelle: Wallstreet online
DGAP-News: WILEX AG: Phase III ARISER data for the adjuvant treatment of clear cell renal cancer with RENCAREX(R) including retrospective subgroup analysis presented at ASCO
DGAP-News: WILEX AG / Key word(s): Research Update WILEX AG: Phase III ARISER data for the adjuvant treatment of clear cell renal cancer with RENCAREX(R) including retrospective subgroup analysis presented at ASCO 03.06.2013 / …
Weiterlesen bei Wallstreet online
JustMac.info